CLINICAL_TRIALS
trial_result
· 2017-08-02
Clinical Trial Update: Exploratory Study in Achievement of Improved Survival by Molecular Targeted Chemotherapy and Liver Resection for Not Optimally Resectable Colorectal Liver Metastases [NA]
Summary
This completed exploratory trial evaluated whether combining molecular targeted chemotherapy with liver resection improves survival for colorectal cancer that h…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: EPS Corporation | Conditions: Liver Metastasis, Colorectal Cancer | NA | Status: COMPLETED